Graf Akcie DCPH (Deciphera Pharmaceuticals Inc). Diskuze k akciím DCPH. Aktuální informace DCPH.

Základní informace o společnosti Deciphera Pharmaceuticals Inc (Akcie DCPH)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 1.86B
Hodnota podniku (EV) N/A
Tržby 83.664M
EBITDA N/A
Zisk -258.17
Růst v tržbách Q/Q 232.48 %
Růst v tržbách Y/Y N/A %
P/E (Cena vůči ziskům) 0.00
Forward P/E 0.34
EV/Sales 18.52
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 22.21
P/FCF N/A
Price/Book 3.42
Účetní hodnota na akcii 9.37
Hotovost na akcii 9.51
FCF vůči ceně -11.89 %
Počet zaměstnanců 350
Tržba na zaměstnance 239.040k
Profit margin -633.19 %
Operating margin -309.58 %
Gross margin 99.47 %
EBIT margin -308.58 %
EBITDA margin -884.46 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst 0.83 %
EPS - Očekávaný růst příští rok 12.39 %
Return on assets -42.36 %
Return on equity -50.07 %
ROIC -42.14 %
ROCE -54.41 %
Dluhy/Equity 0.18
Čistý dluh/EBITDA 11.73
Current ratio 6.62
Quick Ratio 6.49
Volatilita 5.44
Beta 0.98
RSI 48.09
Cílová cena analytiků 76
Známka akcie (dle analytiků) 1.36
Insider ownership N/A %
Institutional ownership N/A %
Počet akcií 58.041M
Procento shortovaných akcií 6.26 %
Short ratio 7.05 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2017
Země United States

Finanční výsledky akcie DCPH

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$42.087$25----
Cost Of Goods Sold$0.225-----
Gross Profit$41.862$25----
Research And Development Expenses$198.97$157.61$82.887$39.514$20.163$12.475
SG&A Expenses$114.082$68.116$21.212$11.421$5.675$5.135
Other Operating Income Or Expenses------
Operating Expenses$313.277$225.726$104.099$50.935$25.838$17.61
Operating Income$-271.19$-200.726$-104.099$-50.935$-25.838$-17.61
Total Non-Operating Income/Expense$4.701$8.47$4.245$0.651$-0.102$-2.206
Pre-Tax Income$-266.489$-192.256$-99.854$-50.284$-25.94$-19.816
Income Taxes------
Income After Taxes$-266.489$-192.256$-99.854$-50.284$-25.94$-19.816
Other Income------
Income From Continuous Operations$-266.489$-192.256$-99.854$-50.284$-25.94$-19.816
Income From Discontinued Operations------
Net Income$-266.489$-192.256$-99.854$-50.284$-25.94$-19.816
EBITDA$-268.885$-199.896$-103.782$-50.785$-25.748$-17.537
EBIT$-271.19$-200.726$-104.099$-50.935$-25.838$-17.61
Basic Shares Outstanding56433517124
Shares Outstanding56433517124
Basic EPS$-4.78$-4.48$-2.82$-2.99$-2.23$-4.67
EPS - Earnings Per Share$-4.78$-4.48$-2.82$-2.99$-2.23$-4.67
# 2020 2019 2018 2017 2016 2015
Current Ratio8.34439.883913.236514.345412.7838.6502
Long-term Debt / Capital--0.00390.0070.02720.0707
Debt/Equity Ratio--0.00460.00810.03150.0846
Gross Margin99.4654100----
Operating Margin-644.3557-802.9041----
EBIT Margin-644.3557-802.9041----
EBITDA Margin-638.879-799.584----
Pre-Tax Profit Margin-633.186-769.024----
Net Profit Margin-633.186-769.024----
Asset Turnover0.06550.0402----
Inventory Turnover Ratio0.0394-----
Receiveable Turnover3.0287-----
Days Sales In Receivables120.5132-----
ROE - Return On Equity-49.0161-35.1816-35.6646-27.332318.560417.1854
Return On Tangible Equity-49.0161-35.1816-35.6646-27.3323-49.0294-89.8237
ROA - Return On Assets-41.4813-30.889-31.6435-25.2563-44.0071-73.9679
ROI - Return On Investment-49.0161-35.1816-35.5241-27.1414-47.6944-83.4709
Book Value Per Share9.439510.58687.43115.6447--
Operating Cash Flow Per Share-0.8143-1.0304-0.2665-0.19961.139-3.1251
Free Cash Flow Per Share-0.7943-1.1137-0.2741-0.20471.1533-3.1585

Porovnání s konkurencí: Akcie DCPH

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
DCPH 0.00 N/A N/A % 12.39 % -50.07 % 3.42 -633.19 %
Akcie OCUL 0.00 N/A 344.51 % 19.05 % -174.71 % 10.05 -894.31 %
Akcie OCUL 0.00 N/A 344.51 % 19.05 % -174.71 % 10.05 -894.31 %
Akcie OCUL 0.00 N/A 344.51 % 19.05 % -174.71 % 10.05 -894.31 %

Nedávné obchody insiderů: Akcie DCPH

Jméno Obchod Cena Objem
Michael Douglas Taylor
Director
Option
4 Nov 2020
$1.89 $28,350
Matthew L Sherman
EVP and Chief Medical Officer
Option
16 Nov 2020
$34.43 $92,858
Michael Douglas Taylor
Director
Option
1 Dec 2020
$1.89 $35,910
Matthew L Sherman
EVP and Chief Medical Officer
Option
9 Dec 2020
$34.43 $7,127
Michael Douglas Taylor
Director
Option
4 Jan 2021
$1.89 $35,910
James Arthur Bristol
Director
Option
15 Jan 2021
$3.95 $27,650
Steven L. Hoerter
President and CEO
Option
21 Jan 2021
$25.40 $27,381
Michael Douglas Taylor
Director
Option
1 Feb 2021
$1.89 $15,120
Matthew L Sherman
EVP and Chief Medical Officer
Prodej
16 Feb 2021
$48.87 $6,451
Daniel Lee Flynn
Chief Scientific Officer
Prodej
16 Feb 2021
$48.87 $24,826
Thomas Patrick Kelly
Chief Financial Officer
Prodej
16 Feb 2021
$48.87 $25,608

Diskuze k akciím DCPH